Even things like protection for the kidneys, um, for diabetics can get big kidney problems, can't they
Long-term appetite suppression from decongestants is not sustainable, and the rebound effect once you stop is usually worse than what you started with
The employer exclusion problem The single biggest barrier to GLP-1 coverage on UnitedHealthcare plans is employer-level exclusions
Monitoring should include periodic blood chemistries, vital signs, plasma carnitine concentrations, and overall clinical condition
Bruising at one or two injection points is possible and fades over two to three days
For the pharmaceutical industry, it reflects the strategic redeployment of capital generated by one of the most successful drug classes in recent history